JP2022117659A - Healthy drink - Google Patents
Healthy drink Download PDFInfo
- Publication number
- JP2022117659A JP2022117659A JP2021014275A JP2021014275A JP2022117659A JP 2022117659 A JP2022117659 A JP 2022117659A JP 2021014275 A JP2021014275 A JP 2021014275A JP 2021014275 A JP2021014275 A JP 2021014275A JP 2022117659 A JP2022117659 A JP 2022117659A
- Authority
- JP
- Japan
- Prior art keywords
- water
- health drink
- silicic acid
- acid
- citric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 135
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 99
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims abstract description 74
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 47
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims abstract description 37
- 235000017557 sodium bicarbonate Nutrition 0.000 claims abstract description 37
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims abstract description 26
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 23
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 23
- 150000007524 organic acids Chemical class 0.000 claims abstract description 17
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 235000012239 silicon dioxide Nutrition 0.000 claims description 87
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims description 85
- 230000036541 health Effects 0.000 claims description 58
- 239000002245 particle Substances 0.000 claims description 55
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 48
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 42
- 235000010755 mineral Nutrition 0.000 claims description 42
- 239000011707 mineral Substances 0.000 claims description 42
- 239000007789 gas Substances 0.000 claims description 28
- 239000000377 silicon dioxide Substances 0.000 claims description 23
- 239000010703 silicon Substances 0.000 claims description 15
- 229910052710 silicon Inorganic materials 0.000 claims description 15
- 239000003673 groundwater Substances 0.000 claims description 3
- 125000005624 silicic acid group Chemical group 0.000 claims description 3
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 abstract 4
- 239000007788 liquid Substances 0.000 description 24
- 230000000694 effects Effects 0.000 description 18
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 16
- 239000002105 nanoparticle Substances 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 229910004283 SiO 4 Inorganic materials 0.000 description 13
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 13
- 238000010521 absorption reaction Methods 0.000 description 13
- 235000014171 carbonated beverage Nutrition 0.000 description 12
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 12
- 239000002101 nanobubble Substances 0.000 description 12
- 238000009826 distribution Methods 0.000 description 10
- 229910052604 silicate mineral Inorganic materials 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 9
- 238000004090 dissolution Methods 0.000 description 9
- 230000035622 drinking Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 7
- 230000005653 Brownian motion process Effects 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 6
- 238000005537 brownian motion Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000003651 drinking water Substances 0.000 description 6
- 235000020188 drinking water Nutrition 0.000 description 6
- 239000012670 alkaline solution Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 210000001986 peyer's patch Anatomy 0.000 description 5
- 102000010637 Aquaporins Human genes 0.000 description 4
- 108010063290 Aquaporins Proteins 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003929 acidic solution Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 238000006253 efflorescence Methods 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000033116 oxidation-reduction process Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 235000021321 essential mineral Nutrition 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052909 inorganic silicate Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 238000006864 oxidative decomposition reaction Methods 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000002407 reforming Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000025467 Gastrointestinal mucosal disease Diseases 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 241000605233 Hydrogenobacter Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 239000004111 Potassium silicate Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000589596 Thermus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000000184 acid digestion Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000005280 amorphization Methods 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 239000010438 granite Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- -1 hydroxide ions Chemical class 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000011089 mechanical engineering Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000036562 nail growth Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 210000004560 pineal gland Anatomy 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- NNHHDJVEYQHLHG-UHFFFAOYSA-N potassium silicate Chemical compound [K+].[K+].[O-][Si]([O-])=O NNHHDJVEYQHLHG-UHFFFAOYSA-N 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- 229910052913 potassium silicate Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229910021655 trace metal ion Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Landscapes
- Non-Alcoholic Beverages (AREA)
Abstract
Description
本発明は、健康飲料に関し、特に、クエン酸と炭酸水素ナトリウムと水溶性ケイ酸とを含有する健康飲料、より好ましくは、クエン酸と炭酸水素ナトリウムとが溶解された溶解水に水溶性ケイ酸が混合され(若しくは、水溶性ケイ酸を含有する改質水にクエン酸と炭酸水素ナトリウムとが溶解され)、炭酸ガスが圧入された健康飲料に関する。 The present invention relates to a health drink, particularly a health drink containing citric acid, sodium hydrogencarbonate and water-soluble silicic acid, more preferably water-soluble silicic acid in dissolved water in which citric acid and sodium hydrogencarbonate are dissolved. is mixed (or citric acid and sodium hydrogen carbonate are dissolved in modified water containing water-soluble silicic acid) and carbon dioxide gas is pressurized.
一般的な炭酸飲料はクエン酸や果汁を含有し多くは甘味料をも含有しており、嗜好性に限定したものが多かった。特に外資系の炭酸飲料には、水素イオン濃度(pH)が2.0~2.5程度の酸性のものが多く、毎日の飲用によって胃の内壁を潰瘍化させる恐れがあり、健康被害が懸念されていた。これらは口当たりがよく、常習性があり、若年世代には人気の飲料品であるが、就労期を迎える世代にとっては、生活変化についていけない胃の病的潰瘍体質が影響を与えており、胃がん検診の際に胃潰瘍の病歴で判断されやすい。 Common carbonated drinks contain citric acid and fruit juice, and many also contain sweeteners, and many of them are limited to palatability. In particular, many foreign carbonated beverages are acidic, with a hydrogen ion concentration (pH) of about 2.0 to 2.5. These beverages are delicious and addictive, and are popular among the younger generation. It is easy to judge by the history of gastric ulcer.
健康維持体質を守るには、上記の胃の消化管粘膜障害に限らず、神経疾患・肺疾患・過敏症・肝疾患・腎疾患・眼疾患・皮膚疾患・その他、糖尿病疾患・免疫疾患等を予防する必要があり、生活習慣のアンバランスで生じる健康への防備から、日常飲用することで健康に配慮した飲料等が求められていた。 In order to maintain a healthy constitution, not only gastrointestinal mucosal disorders mentioned above, but also neurological diseases, pulmonary diseases, hypersensitivity, liver diseases, renal diseases, eye diseases, skin diseases, diabetes diseases, immune diseases, etc. There is a need for prevention, and from the viewpoint of defense against health caused by unbalanced lifestyle habits, there has been a demand for beverages and the like that are health-conscious by daily drinking.
健康維持には各種ミネラルが必要であり、近年、ケイ素が注目されている。本来、ケイ素は日本国内において必須ミネラル項目16には含まれていないが、ドイツ等欧米では4番目にケイ素が順位し、幼児期の骨細胞補強として常用されていた。日本国内では、約15年前より分析科学の進歩でナノ粒子化学が発展を始め、ナノ技術の伸展とともにケイ酸科学の認識で健康産業への活用が始まっている。 Various minerals are necessary for health maintenance, and in recent years, silicon has attracted attention. Originally, silicon is not included in the 16 essential minerals in Japan, but in Europe and the United States, such as Germany, silicon ranks fourth and was commonly used to reinforce osteocytes during childhood. In Japan, nanoparticle chemistry began to develop about 15 years ago due to advances in analytical science.
このような背景から、ケイ素を含む飲料が開発されており、例えば、「のむシリカ」といった商品名の飲料も販売されている。また、下記特許文献1には、飲料水に無色・無臭・無味の純度(濃度)の高いケイ素の液体を混入する飲料水が開示されている。 Against this background, beverages containing silicon have been developed and, for example, beverages under the trade name of "Nomu Silica" are on the market. Moreover, the following patent document 1 discloses drinking water in which a colorless, odorless and tasteless silicon liquid having high purity (concentration) is mixed into the drinking water.
ケイ素は非水溶性のシリカ(SiO2)や水溶性のケイ酸(SiO4)などの形態で存在するが、ヒトの健康維持に必要なのはケイ酸であって、シリカはスケール付着の要因となる物質である。また、ケイ酸は主にアクアポリン(細胞膜)や腸内のパイエル板などで吸収されるが、ケイ酸のサイズや溶液のpHなどによって吸収効率が大きく変化し、特にケイ酸のサイズを適切に管理しないとケイ酸を効率的に体内に取り込めないという問題があった。 Silicon exists in forms such as water-insoluble silica (SiO 2 ) and water-soluble silicic acid (SiO 4 ), but silicic acid is necessary for maintaining human health, and silica is a factor in the adhesion of scale. It is matter. In addition, silicic acid is mainly absorbed by aquaporins (cell membranes) and Peyer's patches in the intestine. Otherwise, there is a problem that silicic acid cannot be efficiently taken into the body.
本発明は、上記問題点に鑑みてなされたものであって、その主たる目的は、ケイ酸を効率的に体内に取り込むことができる健康飲料を提供することにある。 SUMMARY OF THE INVENTION The present invention has been made in view of the above problems, and a main object thereof is to provide a health drink capable of efficiently taking silicic acid into the body.
本発明の一側面は、健康飲料に、有機酸としてのクエン酸と、重炭酸塩としての炭酸水素ナトリウムと、水溶性ケイ酸と、を含有することを特徴とする。 One aspect of the present invention is characterized by containing citric acid as an organic acid, sodium hydrogen carbonate as a bicarbonate, and water-soluble silicic acid in a health drink.
本発明によれば、ケイ酸を効率的に体内に取り込むことができ、生活習慣の健康維持に不可欠な体調管理を可能とし、かつ、常飲しても消化器系や精神的にも悪影響の無い、真に健康づくりに寄与する健康飲料を提供することができる。 According to the present invention, silicic acid can be efficiently taken into the body, enabling physical condition management essential for maintaining healthy lifestyle habits, and even if it is taken regularly, it does not adversely affect the digestive system and mental health. It is possible to provide a health drink that truly contributes to health promotion.
その理由は、有機酸としてのクエン酸と、クエン酸に対して良好な緩衝能力(バッファー性)を発揮する重炭酸塩としての炭酸水素ナトリウムと、が溶解された溶解水に、温泉水や湧出地下水などから抽出された所定サイズ以下の水溶性ケイ酸を混合し、必要に応じて炭酸ガスを圧入して、健康飲料を製造するからである。若しくは、所定サイズ以下の水溶性ケイ酸を含有する改質水などに、有機酸としてのクエン酸と重炭酸塩としての炭酸水素ナトリウムとを溶解し、必要に応じて炭酸ガスを圧入して、健康飲料を製造するからである。 The reason is that citric acid as an organic acid and sodium bicarbonate as a bicarbonate that exerts a good buffering capacity (buffer property) against citric acid are dissolved in the dissolved water, which is used in hot spring water and spring water. This is because a health drink is produced by mixing water-soluble silicic acid of a predetermined size or smaller extracted from groundwater or the like and, if necessary, injecting carbon dioxide gas. Alternatively, citric acid as an organic acid and sodium bicarbonate as a bicarbonate are dissolved in modified water containing water-soluble silicic acid of a predetermined size or less, and if necessary, carbon dioxide gas is injected, This is because they manufacture health drinks.
チェコ・温泉コロネード:Vridelni Kolonadaは飲泉の発祥地として知られている。この飲泉の発祥地では、「野菜を食べる以上に貴重な健康づくり」という考えがあり、飲用対象として珍重してきたのは、すべて良質の炭酸温泉であり、498年にさかのぼる歴史的習慣からである。 Czech spa colonnade: Vridelni Kolonada is known as the birthplace of drinking springs. In this birthplace of drinking hot springs, there is an idea that "health promotion is more valuable than eating vegetables", and all of the high-quality carbonated hot springs that have been prized for drinking are from a historical custom that goes back to 498. be.
また、18世紀後半、カールスバッド医師のデイビッド・ベシェルはカルロヴィヴァリの海域で二酸化炭素を発見し、二酸化炭素の影響が最も強い温泉で直接ミネラルウォーターを飲むよう患者に勧めた。 Also, in the late 18th century, Carlsbad doctor David Bechel discovered carbon dioxide in the waters of Karlovy Vary and advised his patients to drink mineral water directly from the hot springs where the carbon dioxide had the strongest effect.
本願発明者は、日本国内の様々な温泉を調査した結果、大分県竹田市の長湯温泉の水質が飲泉の発祥地であるチェコ・温泉コロネードの水質と近似していることを発見した。この長湯温泉水も、海域での二酸化炭素に等しくpHは中性で重炭酸イオンが主成分であり、飲泉により、糖尿病に代表的される様々な病気に効果があることが慶応大学などの臨床試験で研究されている。さらに重炭酸イオンによる良好な緩衝能力により胃酸を中和し、胆汁の分泌を促すことなどから、胃腸や肝臓、すい臓の働きを活発にする作用があるとされている。 As a result of investigating various hot springs in Japan, the inventor of the present application found that the water quality of Nagayu Hot Spring in Taketa City, Oita Prefecture is similar to the water quality of Hot Spring Colonnade in Czech Republic, the birthplace of drinking hot springs. This Nagayu hot spring water has a neutral pH, similar to carbon dioxide in the ocean, and is mainly composed of bicarbonate ions. Being studied in clinical trials. Furthermore, due to its good buffering capacity due to bicarbonate ions, it neutralizes gastric acid and promotes the secretion of bile.
そこで、本願発明者はこの重炭酸の効果に着目し、先願(特許第6698766号)において、有機酸としてのクエン酸及び重炭酸塩としての炭酸水素ナトリウム(重炭酸ナトリウム)を含有する炭酸飲料を発明した。この炭酸飲料は、腸内フローラによる血糖値上昇を抑制する効果があるが、更なる細胞等への機能性強化向上のために、腸内環境から体内への吸収能力に優れた微細サイズのケイ素を水溶性のケイ酸として含む健康飲料の開発を行った。 Therefore, the inventor of the present application focused on the effect of this bicarbonate, and in a previous application (Patent No. 6698766), a carbonated beverage containing citric acid as an organic acid and sodium hydrogen carbonate (sodium bicarbonate) as a bicarbonate invented. This carbonated drink has the effect of suppressing the increase in blood sugar level caused by intestinal flora. was developed as a water-soluble silicic acid.
このケイ酸は、保湿効果や美肌効果、毛髪や爪の発育と皮膚細胞の活性化する効果があり、女性にとっては、しばしば『美しさのミネラル』と呼ばれている。ケイ酸を飲む効果として、認知症予防、骨粗しょう症予防、皮膚・爪・コラーゲンの生成、免疫機能の改善、血管の柔軟性を保つ等が発表され、ケイ酸は健康の基礎づくりで重要度を増し、医学分野でも遠赤外線放射「癌」治療に用いられている。また、最新の研究では、ケイ酸が不足することで、脳を活性化させる松果体・セロトニンの分泌が減少し、心の病である『うつ』や『精神不安』が起こることが報告されている。 This silicic acid has a moisturizing effect, a skin-beautifying effect, and an effect of activating hair and nail growth and skin cells, and is often called a "beauty mineral" for women. The effects of drinking silicic acid include preventing dementia, preventing osteoporosis, producing skin, nails, and collagen, improving immune function, and maintaining the flexibility of blood vessels. It is also used in the medical field for far-infrared radiation "cancer" treatment. In addition, the latest research reports that a lack of silicic acid reduces the secretion of the pineal gland and serotonin, which activates the brain, causing mental illnesses such as "depression" and "anxiety." ing.
上述したようにケイ酸は腸内のパイエル板などで吸収される。更に、ケイ酸の人体への吸収については、植物もヒトも同じ傾向にあり、植物は根酸により土質のケイ素の0.01%がケイ酸に変貌し、ケイ酸は植物組織の細胞間隙と細胞壁からなるアポプラスト部分を通じて根の中心部に向かって動く。また、医薬品(錠剤の賦形剤・滑沢剤)として用いられるタルク(ケイ酸マグネシウム・Mg2SiO4)も胃酸でよりケイ酸化が進行し、健康維持に役立っている。そして、ケイ酸コロイド粒子は、ヒトのアクアポリン及び腸壁(パイエル板)より通過し血中にて老廃物をデトックスさせる作用に役立つ。 As mentioned above, silicic acid is absorbed by Peyer's patches in the intestine. Furthermore, regarding the absorption of silicic acid into the human body, both plants and humans have the same tendency. It moves towards the center of the root through the apoplast segment. In addition, talc (magnesium silicate, Mg 2 SiO 4 ), which is used as a pharmaceutical (tablet excipient/lubricant), is further silicified by stomach acid and is useful for maintaining health. The colloidal silicate particles pass through human aquaporins and the intestinal wall (Peyer's patch) to help detox wastes in the blood.
このケイ酸の体内への吸収効率は、ケイ酸のサイズや溶液のpHなどによって大きく変化する。特に、ケイ酸を効率的に体内に取り込むためには、水溶性ケイ酸からなるコロイド粒子のサイズを小さくすることが重要であり、100nm以下、特に、論文(Henk-Maarten Laane 2018, The Effects of Foliar Sprays with Different Silicon Compounds,Plant,7,45;doi:10.3390/plants7020045)などに紹介されているように、葉面散布において最も一般的に使用されている40nm以下のサイズが人間の腸管からの吸収においても好適である。 The absorption efficiency of this silicic acid into the body varies greatly depending on the size of the silicic acid and the pH of the solution. In particular, in order to efficiently incorporate silicic acid into the body, it is important to reduce the size of colloidal particles made of water-soluble silicic acid. Foliar Sprays with Different Silicon Compounds, Plant, 7, 45; It is also suitable for absorption.
そこで、本願発明者は、上述した先願(特許第6698766号)に記載した、有機酸としてのクエン酸及び重炭酸塩としての炭酸水素ナトリウム(重炭酸ナトリウム)を含む溶解水に水溶性ケイ酸を混合し(若しくは、水溶性ケイ酸を含有する改質水にクエン酸及び炭酸水素ナトリウムを溶解し)、必要に応じて炭酸ガスを圧入した健康飲料の発明に至った。 Therefore, the inventors of the present application described in the above-mentioned prior application (Patent No. 6698766) that water-soluble silicic acid (or dissolving citric acid and sodium bicarbonate in modified water containing water-soluble silicic acid), and injecting carbon dioxide gas as necessary, resulting in the invention of a health drink.
上記水溶性ケイ酸は、例えば、本願発明者の他の先願(特許第6328403号)に記載した機能性水製造装置を用いて抽出することができ、コロイド粒子のサイズを100nm以下、特に、40nm以下に調整することにより、体内への吸収効率を格段に高めることができる。また、この健康飲料のクエン酸(微酸性pH4)や混合炭酸水(pH2.5)がケイ素をケイ酸に変貌させる作用に役立っている。 The water-soluble silicic acid can be extracted, for example, using the functional water production device described in another prior application of the present inventor (Patent No. 6328403), and the size of the colloidal particles is reduced to 100 nm or less. By adjusting the wavelength to 40 nm or less, the absorption efficiency into the body can be significantly increased. In addition, the citric acid (slightly acidic pH 4) and mixed carbonated water (pH 2.5) in this health drink help transform silicon into silicic acid.
なお、本発明のコロイド粒子は、水溶性ケイ酸を含んでいればよく、水溶性ケイ酸が集合したコロイド粒子や水溶性ケイ酸に他のミネラルが共有結合したコロイド粒子を含む。また、コロイド粒子のサイズは、ナノ粒子解析装置(例えば、英国製マルバーン社・日本カンタムデザイン(株)LM10型)を用いて測定することができる。 The colloidal particles of the present invention need only contain water-soluble silicic acid, and include colloidal particles in which water-soluble silicic acid aggregates and colloidal particles in which other minerals are covalently bonded to water-soluble silicic acid. In addition, the size of the colloidal particles can be measured using a nanoparticle analyzer (for example, LM10 manufactured by Malvern Co., Ltd., manufactured by British Quantum Design Co., Ltd.).
上記した本発明の一実施の形態についてさらに詳細に説明すべく、本発明の一実施例に係る健康飲料について、図1乃至図4を参照して説明する。図1は、水溶性ケイ酸からなるコロイド粒子のサイズと体内への吸収効率との相関を示す図である。また、図2及び図3は、従来の飲料のナノ粒子の分布図及びNANOSIGHT分析結果であり、図4は、本発明のクエン酸と炭酸水素ナトリウムと水溶性ケイ酸とを含む健康飲料のナノ粒子の分布図及びNANOSIGHT分析結果である。 A health drink according to an embodiment of the present invention will be described with reference to FIGS. FIG. 1 is a diagram showing the correlation between the size of colloidal particles made of water-soluble silicic acid and the absorption efficiency into the body. 2 and 3 are distribution maps of nanoparticles in conventional beverages and NANOSIGHT analysis results, and FIG. It is a distribution map of particles and NANOSIGHT analysis results.
まず、本願発明者の先願(特許第6698766号)に記載したクエン酸含有炭酸飲料について概説する。このクエン酸含有炭酸飲料は、有機酸としてのクエン酸及び重炭酸塩としての炭酸水素ナトリウムを含有する溶解水である炭酸飲料であり、該炭酸飲料1,000ml中にクエン酸が0.3~0.9gで溶解された炭酸飲料であって、前記溶解水は、クエン酸1に対し炭酸水素ナトリウムが2~8の割合(質量比)で溶解されたものであり、かつ、前記溶解水に対し炭酸ガスが1,000~10,000ppm含有されていることを特徴とするものである。ここで、有機酸としてはリンゴ酸やコハク酸、フマル酸などが良く知られコストも安いが、クエン酸だけがケイ酸の腸内吸収が良く、健康効果が高いという特徴があり、本発明では好ましく使われる有機酸である。 First, the citric acid-containing carbonated beverage described in the inventor's prior application (Japanese Patent No. 6698766) will be outlined. This citric acid-containing carbonated beverage is a carbonated beverage that is dissolved water containing citric acid as an organic acid and sodium hydrogen carbonate as a bicarbonate, and 0.3 to 0.9 g of citric acid per 1,000 ml of the carbonated beverage. A dissolved carbonated beverage, wherein the dissolution water contains 2 to 8 sodium bicarbonate dissolved in 1 part citric acid (mass ratio), and carbon dioxide gas is added to the dissolution water. It is characterized by containing 1,000 to 10,000 ppm. Here, as organic acids, malic acid, succinic acid, fumaric acid, etc. are well known and are inexpensive, but only citric acid is characterized by good intestinal absorption of silicic acid and high health effects. Organic acids are preferably used.
このクエン酸含有炭酸飲料の製造装置は、例えば、酸性溶液を収容するタンクとアルカリ性溶液を収容するタンクとを隣接配置してセットしている装置であり、酸性溶液を収容するタンクには、所定量の水に所定量のクエン酸を混合攪拌させて溶解した酸性溶液を入れ、アルカリ性溶液を収容するタンクには、所定量の水に所定量の重曹を混合攪拌させて溶解したアルカリ性溶液を入れる。 This citric acid-containing carbonated beverage manufacturing apparatus is, for example, an apparatus in which a tank containing an acidic solution and a tank containing an alkaline solution are arranged adjacent to each other. An acidic solution prepared by mixing and stirring a predetermined amount of citric acid in a fixed amount of water is added, and an alkaline solution prepared by mixing and stirring a predetermined amount of sodium bicarbonate in a predetermined amount of water is added to a tank containing the alkaline solution. .
酸性溶液の収容タンク内に混合溶解させるクエン酸とアルカリ性溶液の収容タンク内に混合溶解させる重曹(炭酸水素ナトリウム)として食用添加物グレードのものを使用することにより飲用に適するものとなすことができる。 The citric acid to be mixed and dissolved in the acidic solution storage tank and the baking soda (sodium hydrogen carbonate) to be mixed and dissolved in the alkaline solution storage tank can be made drinkable by using edible additive grade sodium bicarbonate. .
また、酸性溶液とアルカリ性溶液とを混合する際に、クエン酸:重曹=1:2~8(質量比)となるようにする。重曹の比率が2未満であると、クエン酸と炭酸水素ナトリウムとが激しく中和反応を起こして、目視可能なほどの泡径の炭酸ガスが発生し、炭酸ガスの大半は水に溶解することなく液外に揮散してしまうという不都合があり、一方、重曹の比率が8を超えると、発生した炭酸ガスの水への溶解度が落ちてしまうという不都合がある。 Also, when mixing the acidic solution and the alkaline solution, citric acid: sodium bicarbonate = 1:2 to 8 (mass ratio). If the ratio of sodium bicarbonate is less than 2, citric acid and sodium bicarbonate will undergo a vigorous neutralization reaction, generating carbon dioxide gas with a bubble diameter that is visible to the naked eye, and most of the carbon dioxide gas will dissolve in water. On the other hand, if the ratio of sodium bicarbonate exceeds 8, there is an inconvenience that the solubility of the generated carbon dioxide gas in water decreases.
そして、水にクエン酸:重曹を1:2~8(質量比)の比率で含有する溶解水に、1,000ppm~10,000ppm濃度で炭酸ガスを圧入してクエン酸含有炭酸飲料が完成する。1,000ppm未満の圧入量では、炭酸飲料水中に溶解している総炭酸ガス濃度が、血糖値上昇抑制効果を生み出すには不十分であるという不都合があり、一方、圧入量が10,000ppmを超えると、逆に血糖値上昇抑制効果が低減するという不都合がある。 Carbonic acid gas containing 1,000 ppm to 10,000 ppm is pressurized into dissolved water containing citric acid: sodium bicarbonate in water at a ratio of 1:2 to 8 (mass ratio) to complete a citric acid-containing carbonated beverage. If the injection amount is less than 1,000 ppm, the total concentration of carbon dioxide gas dissolved in the carbonated beverage is insufficient to produce the effect of suppressing the increase in blood sugar level. , Conversely, there is the inconvenience that the effect of suppressing the increase in blood sugar level is reduced.
次に、本願発明者の他の先願(特許第6328403号)に記載した機能性水製造装置について概説する。この機能性水製造装置は、水にオゾンガスをナノバブル化して、気液混合水を生成する工程と、ミネラル成分溶出手段において前記気液混合水を天然鉱物に接触させ、当該天然鉱物のミネラル成分を溶出させる工程とを備えた機能性水製造方法において、前記ミネラル溶出手段の容積を、前記水の送水量の2~5分の滞留時間により設定し、前記天然鉱物の充填量を、前記水の潜在的なミネラル成分に基づいて、目的の基準値に応じて、前記天然鉱物の粒度又は体積により調整し、前記気液混合水の酸化還元電位が650mVとなるように前記気液混合水の温度に応じて前記オゾンガスの注入量を制御することを特徴とするものである。 Next, the functional water production apparatus described in another prior application (Japanese Patent No. 6328403) of the inventor of the present application will be outlined. This functional water production apparatus includes a step of forming gas-liquid mixed water by nanobubbles of ozone gas in water, and a mineral component elution means for bringing the gas-liquid mixed water into contact with natural minerals to extract the mineral components of the natural minerals. In the method for producing functional water comprising the step of eluting, the volume of the mineral eluting means is set by a retention time of 2 to 5 minutes of the water supply rate, and the filling amount of the natural mineral is set by the amount of the water. Based on potential mineral components, the temperature of the gas-liquid mixed water is adjusted according to the desired reference value, depending on the particle size or volume of the natural mineral, so that the oxidation-reduction potential of the gas-liquid mixed water is 650 mV. The injection amount of the ozone gas is controlled according to the above.
この機能性水製造装置は、例えば天然水等の被処理水を導入する被処理水導入ポートと、当該被処理水導入ポートから導入された被処理水の異物を除去する第1ろ過フィルタと、この第1ろ過フィルタを通過した被処理水にオゾンガスをナノバブル化して溶解させて気液混合水を生成する加圧溶解手段と、この加圧溶解手段により生成された気液混合水を天然鉱物に接触させて天然鉱物のミネラル成分を溶出させるミネラル溶出手段と、このミネラル溶出手段から導出された気液混合水の異物を除去する第2ろ過フィルタと、この第2ろ過フィルタを通過した気液混合水(機能性水)を導出する機能性水導出ポートと、これらの構成要素をこの順で直列に接続する接続配管とで構成されている。 This functional water production apparatus includes, for example, a water-to-be-treated introduction port for introducing water to be treated such as natural water; pressure dissolving means for forming gas-liquid mixed water by forming ozone gas into nanobubbles and dissolving it in the water to be treated that has passed through the first filtration filter to generate gas-liquid mixed water; Mineral eluting means for eluting mineral components of natural minerals by contact, a second filtering filter for removing foreign matter from the gas-liquid mixed water derived from the mineral eluting means, and the gas-liquid mixing that has passed through the second filtering filter. It is composed of a functional water lead-out port for leading out water (functional water) and a connection pipe that connects these components in series in this order.
上記加圧溶解手段は、オゾンガスをナノバブル化して被処理水に溶解して気液混合水を生成するものであり、オゾンガスを発生させるオゾン発生手段と、被処理水を加圧する加圧ポンプと、オゾンガス及び加圧された被処理水が導入され、オゾンガスをナノバブル化して被処理水に溶解させる加圧せん断溶解槽とを有する。この加圧せん断溶解槽は、オゾンガスを加圧せん断溶解法によりナノバブル化(微細気泡化)して被処理水に溶解させるものであり、オゾン発生手段により生成されたオゾンガスを導入するオゾンガス導入ポートと、加圧ポンプにより加圧された被処理水を導入する加圧水導入ポートと、当該加圧せん断溶解槽により生成された気液混合水を導出する気液混合水導出ポートとを有する。この加圧せん断溶解層により生成されるナノバブルは、直径200nm以下である。 The pressurized dissolution means converts ozone gas into nanobubbles and dissolves it in the water to be treated to generate gas-liquid mixed water. It has a pressurized shear dissolution tank into which ozone gas and pressurized water to be treated are introduced, converts the ozone gas into nanobubbles and dissolves it in the water to be treated. This pressurized shear dissolution tank converts ozone gas into nanobubbles (microbubbles) by the pressurized shear dissolution method and dissolves it in the water to be treated. , a pressurized water inlet port for introducing water to be treated pressurized by a pressurizing pump, and a gas-liquid mixed water outlet port for leading out gas-liquid mixed water generated by the pressurized shear dissolution tank. Nanobubbles generated by this pressurized shear dissolution layer have a diameter of 200 nm or less.
また、上記ミネラル溶出手段は、加圧溶解手段により生成された気液混合水にミネラル成分を溶出させるものであり、内部に天然鉱物(ケイ酸塩を含んだ天然鉱石)が充填されたミネラル溶出槽を有する。このミネラル溶出槽は、加圧せん断溶解槽の気液混合水導出ポートに連通する気液混合水導入ポートと、気液混合水にミネラル成分が溶出することにより生成される機能性水を導出する導出ポートとを有する。 Further, the mineral eluting means is for eluting mineral components into the gas-liquid mixed water generated by the pressurized dissolving means, and the mineral eluting means is filled with natural minerals (natural ore containing silicate). have a tank. This mineral elution tank has a gas-liquid mixed water inlet port that communicates with the gas-liquid mixed water outlet port of the pressurized shear dissolution tank, and leads out functional water generated by eluting mineral components into the gas-liquid mixed water. and a lead-out port.
上記の気液混合水(機能性水)に天然鉱物のミネラル成分を溶出させる方法として、化学的風化及び物理的風化の両方を利用することができる。 Both chemical weathering and physical weathering can be used as a method for eluting mineral components of natural minerals into the gas-liquid mixed water (functional water).
化学的風化とは、気液混合水に含まれるナノバブル化したオゾンガスによるオゾン酸化反応を利用して天然鉱物に含まれるミネラル成分を気液混合水に溶出させることである。この化学的風化をもたらすオゾン酸化反応は、酸性領域(pH<7)では、オゾン自体の強い酸化力による酸化分解であり、アルカリ性領域(pH>7)では、水酸化物イオン濃度が高いため、酸化力の強いヒドロキシラジカルが生成され、このヒドロキシラジカルの酸化力による酸化分解である。ここで、酸化剤が酸化しやすいか還元しやすいかは酸化還元電位(ORP)として表され、プラスの値が大きいほど酸化力が大きく、マイナスの値が大きいほど還元力が大きい。 Chemical weathering is the elution of mineral components contained in natural minerals into the gas-liquid mixed water by utilizing the ozone oxidation reaction caused by nano-bubbled ozone gas contained in the gas-liquid mixed water. The ozone oxidation reaction that causes this chemical weathering is oxidative decomposition due to the strong oxidizing power of ozone itself in the acidic region (pH < 7), and in the alkaline region (pH > 7), due to the high concentration of hydroxide ions, Hydroxyl radicals with strong oxidative power are generated, and oxidative decomposition is caused by the oxidative power of these hydroxy radicals. Here, whether the oxidizing agent is easily oxidized or easily reduced is represented by the oxidation-reduction potential (ORP). The larger the positive value, the greater the oxidizing power, and the larger the negative value, the greater the reducing power.
一方、物理的風化とは、気液混合水に含まれるナノバブル化したオゾンガスの物理的な挙動によって天然鉱物の粒子を物理的に削り、当該天然鉱物に含まれるミネラル成分を溶出させることである。この物理的風化をもたらすナノバブル化したオゾンガスの物理的な挙動は、ブラウン運動であり、当該ブラウン運動の速度は、液体の温度、粘度及びナノバブルの粒子径に依存する。したがって、液体の温度及び粘度が同一であれば、ブラウン運動速度はナノバブルの粒子径によって変化する。具体的には、ナノバブル径が小さいほどブラウン運動速度が大きくなり、ナノバブル径が大きいほどブラウン運動速度が小さくなる。 On the other hand, physical weathering is to physically scrape particles of natural minerals by the physical behavior of nano-bubbled ozone gas contained in gas-liquid mixed water to elute mineral components contained in the natural minerals. The physical behavior of the nanobubbled ozone gas that causes this physical weathering is Brownian motion, and the speed of the Brownian motion depends on the temperature and viscosity of the liquid and the particle size of the nanobubbles. Therefore, if the temperature and viscosity of the liquid are the same, the Brownian motion velocity changes depending on the particle size of the nanobubbles. Specifically, the smaller the nanobubble diameter, the higher the Brownian motion speed, and the larger the nanobubble diameter, the lower the Brownian motion speed.
このように構成した機能性水製造装置によれば、ミネラル溶出手段において、気液混合水に、オゾンの酸化反応による化学的風化、及びナノバブルの挙動による物理的風化の両方を使用して天然鉱物(ケイ酸塩を含んだ天然鉱石)からミネラル成分を溶出させることができる。 According to the functional water production apparatus configured as described above, the mineral elution means applies both chemical weathering due to the oxidation reaction of ozone and physical weathering due to the behavior of nanobubbles to the gas-liquid mixed water to extract natural minerals. Mineral components can be eluted from (natural ore containing silicate).
本願は、上記2つの先願を利用し、有機酸としてのクエン酸及び重炭酸塩としての炭酸水素ナトリウムが溶解された溶解水に水溶性ケイ酸を混合し(若しくは、水溶性ケイ酸を含有する改質水にクエン酸及び炭酸水素ナトリウムを溶解し)、必要に応じて、炭酸ガスを圧入して健康飲料を製造することにより、水溶性ケイ酸からなるコロイド粒子のサイズを調整し、ケイ素や他のミネラルの体内への吸収効率を高めている。例えば、上記機能性水製造装置を用いてナノサイズの水溶性ケイ酸を抽出したり、製造段階で炭酸ガスの圧力や含有量、pHを調整することによりケイ素のケイ酸化やケイ酸の微細化を促進したりして、健康飲料に所望のコロイド粒子サイズの水溶性ケイ酸が多く含まれるようにしている。 The present application utilizes the above two prior applications and mixes water-soluble silicic acid with dissolved water in which citric acid as an organic acid and sodium hydrogen carbonate as a bicarbonate is dissolved (or citric acid and sodium bicarbonate are dissolved in the modified water), and if necessary, carbon dioxide gas is injected to produce a health drink, thereby adjusting the size of colloidal particles composed of water-soluble silicic acid, and other minerals are more efficiently absorbed into the body. For example, nano-sized water-soluble silicic acid can be extracted using the above-mentioned functional water production equipment, or the silicic acid of silicon and silicic acid can be refined by adjusting the pressure, content, and pH of carbon dioxide gas in the production stage. so that the health drink contains a large amount of the desired colloidal particle size of water-soluble silicic acid.
表1は、ラボでの実験(炭酸ガスによる圧壊)と製造品(クエン酸による酸化及び炭酸ガスによる圧壊)における各サイズの水溶性ケイ酸粒子の粒子個数及び粒子比率を比較した結果を示している。表1より、製造工程上で水溶性ケイ酸粒子は、クエン酸による酸化及び炭酸ガスによる圧壊によりターニング・イフェクトが発現し、10倍の微細効果に変化している(表1中の(1)参照)。 Table 1 shows the results of comparing the number of particles and the particle ratio of water-soluble silicic acid particles of each size in laboratory experiments (collapse by carbon dioxide gas) and manufactured products (oxidation by citric acid and crushing by carbon dioxide gas). there is From Table 1, the water-soluble silicic acid particles in the manufacturing process have a turning effect due to oxidation by citric acid and crushing by carbon dioxide gas, changing to a 10-fold fine effect ((1) in Table 1) reference).
次に、上記溶解水に加える水溶性ケイ酸、特に、他のミネラルと結合した多元素共有水溶性ケイ酸ミネラルについて説明する。 Next, the water-soluble silicic acid added to the dissolved water, especially the multi-element covalent water-soluble silicate mineral combined with other minerals will be described.
地球の形成期の始原的物質が残っているケイ酸塩鉱物溶液には、無機化学モデルのみでは説明できない現象と捉えられているものがある。それは、Thermus・Hydrogenobacter属などの高度好熱性細菌が多元素共有ケイ酸塩鉱物にも存在することであり、この現象がケイ酸塩鉱物溶液の多目的活用を可能とする障壁でもあった。一方、上記機能性水製造装置を用いたオゾン・ナノバブル反応後の酸化還元電位(ORP)650mV以上の反応で微生物の痕跡は皆無であり、本発明で使用する多元素共有ミネラルにも微生物妨害作用が確認されている。 Silicate mineral solutions containing primordial materials from the Earth's formation period have some phenomena that cannot be explained by inorganic chemical models alone. The reason is that highly thermophilic bacteria such as Thermus and Hydrogenobacter are also present in multi-element covalent silicate minerals, and this phenomenon was a barrier to the multi-purpose utilization of silicate mineral solutions. On the other hand, there is no trace of microorganisms in the reaction at an oxidation-reduction potential (ORP) of 650 mV or more after the ozone nanobubble reaction using the above functional water production device, and the multi-element shared mineral used in the present invention has a microbial interference effect. has been confirmed.
本発明では、このメカニズムを利用し、地下マグマで熱せられた蒸気がケイ酸塩鉱物を通過し温泉を非加熱殺菌したものを多元素共有ケイ酸ミネラル溶液の原料としている。具体的には、多元素共有ケイ酸ミネラル溶液は、非加熱殺菌工程で、内部の水のpHと関係なく界面の水はアルカリ性(pH8.5~9.0)を示し、還元作用によって、水が接触する金属表面にM(OH)nという化合物を作る。すなわち、オゾン酸化熱と高圧条件下で酸化・還元反応を経て、ナノサイズ(10~100nm)を促進させ、メタ珪酸(H2SiO3)、メタ二ケイ酸(H2Si2O5)、オルトケイ酸(H4SiO4)等のケイ酸に改質させる。これによって10ナノサイズ以下の活性度の高いケイ酸SiO4基を増幅させて、ケイ酸カルシウム(Ca2SiO4)、ケイ酸マグネシウム(Mg2SiO4)、ケイ酸カリウム(K2SiO3)等、他の二価陽イオンや微量金属イオンの水和物を形成し、ヒトの必須ミネラル補給に貢献している。また、ヒトのタンパク合成に必要なサルフェートも含まれている。 In the present invention, this mechanism is utilized, and steam heated by subterranean magma passes through silicate minerals to sterilize hot springs without heating, which is used as a raw material for a multi-element covalent silicate mineral solution. Specifically, in the multi-element covalent silicate mineral solution, in the non-heat sterilization process, the water at the interface shows alkaline (pH 8.5 to 9.0) regardless of the pH of the internal water, and the reduction action causes the water to contact It creates a compound called M(OH)n on the metal surface. That is, through oxidation/reduction reactions under ozone oxidation heat and high pressure conditions, nanosize (10 to 100 nm) is promoted to form metasilicic acid (H 2 SiO 3 ), metadisilicic acid (H 2 Si 2 O 5 ), It is modified into silicic acid such as orthosilicic acid (H 4 SiO 4 ). This amplifies the highly active silicate SiO 4 groups of 10 nano-size or less to form calcium silicate (Ca 2 SiO 4 ), magnesium silicate (Mg 2 SiO 4 ), and potassium silicate (K 2 SiO 3 ). It forms hydrates of other divalent cations and trace metal ions, etc., and contributes to the supply of essential minerals for humans. It also contains sulfates, which are necessary for human protein synthesis.
そこで重要なのは、消費者はケイ素SiO2(シリカ)の含有量が多ければ良いものと理解する。しかしながら、ヒトの健康維持に必要なのはケイ酸であって、シリカではなく、シリカは、水を取り扱う業務では水中のゴミ扱い(スケール付着)として嫌われる対象である。環境計量分析で判断してもケイ酸≧シリカが必要であり、ケイ酸が主導的反応を牽引する。例えば、医薬成分の血管内伝達効果に用いられるのが水溶性ケイ酸SiO4のドラッグデリバリ作用(ヒドロキシルイオン)である。 Therefore, it is important for consumers to understand that the higher the content of silicon SiO 2 (silica), the better. However, it is silicic acid that is necessary for maintaining human health, not silica, and silica is disliked as waste in water (adhesion of scale) in the business of handling water. Silicic acid ≥ silica is necessary even if judged by environmental quantitative analysis, and silicic acid drives the leading reaction. For example, the drug delivery action (hydroxyl ion) of water-soluble silicate SiO 4 is used for the intravascular delivery effect of medicinal ingredients.
この水溶性ケイ酸SiO4のドラッグデリバリ作用(ヒドロキシルイオン)による医薬成分血管内伝達効果について詳述する。この治療法は、ガン細胞だけに特異的に結合する抗体を利用し、その抗体に近赤外線によって化学反応を起こす物質(IR700)を付け、静脈注射で体内に入れる。抗体はガン細胞に届いて結合するので、そこに近赤外線の光を照射すると、化学反応を起こしてガン細胞を破壊する。近赤外線は、波長が可視光と赤外線の中間に位置する光である。治療には近赤外線で波長が最も短く(700nm)、エネルギーが高い光を使う。 The drug delivery effect (hydroxyl ion) of this water-soluble silicate SiO 4 is described in detail below. This treatment uses an antibody that specifically binds only to cancer cells, attaches a substance (IR700) that causes a chemical reaction to the antibody by near-infrared rays, and injects it into the body by intravenous injection. Antibodies reach and bind to cancer cells, so when they are irradiated with near-infrared light, a chemical reaction occurs and destroys the cancer cells. Near-infrared light is light whose wavelength is intermediate between visible light and infrared light. Near-infrared light with the shortest wavelength (700 nm) and high energy is used for treatment.
IR700はフタロシアニンという色素で、波長700nmの近赤外線のエネルギーを吸収する性質を持つので、その化学反応で変化したIR700が、ガン細胞の膜に照射する抗体の結合したタンパク質を変性させ、細胞膜の機能を失わせることによって1~2分という極めて短時間でガン細胞を破壊するという。この治療法には、ほぼ副作用はなく、安全性が確認されている。 IR700 is a dye called phthalocyanine and has the property of absorbing near-infrared energy with a wavelength of 700 nm. It is said that cancer cells are destroyed in an extremely short time of 1 to 2 minutes by losing This treatment has almost no side effects and has been confirmed to be safe.
そもそもガン以外の正常細胞には抗体が結合しないので、近赤外線が照射しても害はなく、また抗体が結合したガン細胞でもこの特殊な近赤外線光が当たらなければ破壊されない。つまり抗体結合して、かつ光が当たったガン細胞だけを破壊するという高い選択性を持つ治療法であることに脚光を受けている。これほど選択性が高いガンの治療法は過去に無かった。 In the first place, antibodies do not bind to normal cells other than cancer cells, so there is no harm even if they are irradiated with near-infrared rays, and even cancer cells bound to antibodies will not be destroyed unless they are exposed to this special near-infrared light. In other words, it is a highly selective therapeutic method that destroys only cancer cells that bind to antibodies and are exposed to light. Never before has there been such a highly selective treatment for cancer.
このIR700は水に溶けない物質で体内に入らないが、ケイ酸を活用して水に溶ける性質に変えており、術後は1日で尿中に溶けて排出されるので、これもヒトには無害である。 This IR700 is a substance that is insoluble in water and does not enter the body, but it is made soluble in water by using silicic acid. is harmless.
このように、ケイ素SiO2(シリカ)ではなく、水溶性ケイ酸SiO4を利用することにより、水に溶けない物質も体内に取り込むことができるため、カルシウム、マグネシウム、カリウム等のヒトの必須ミネラルの補給に貢献することができる。 In this way, by using water-soluble silicate SiO 4 instead of silicon SiO 2 (silica), it is possible to take in water-insoluble substances into the body, so essential human minerals such as calcium, magnesium, and potassium can contribute to the replenishment of
水溶性ケイ酸の製造方法は、下表に示すように、大別して(1)ケイ酸塩鉱物(水晶・石英等)由来によるもの(特許第4564086号:多孔性球状メタケイ酸コロイド溶液)、(2)黒雲母斑岩や花崗岩を塩酸又は硫酸等の強酸を用いて超微細化した飲用液(ボトルドウオーター)があり、(3)籾殻から抽出した水溶性ケイ酸と称したものも出現している。他方、(4)天城抗火石から溶出するケイ酸溶(0.4ppm/hr)で水道水を改質する家庭備品もあるが、アルミニウムの検出があり、アルツハイマー誘因が難点である。(5)のむシリカ(シリカ97ppm―宮崎県小林市産出)等もある。また、(6)は本発明の健康飲料に使用する一次原料となる、ケイ酸塩鉱物水(温泉水)を改質したものであり、ウイルス不活性・細菌類殺菌を含め天然資源改質段階で機械工学上の反応律速を経て履行され安心である。 As shown in the table below, the methods for producing water-soluble silicic acid are roughly classified into (1) those derived from silicate minerals (crystal, quartz, etc.) (Patent No. 4564086: Porous spherical metasilicate colloidal solution), ( 2) There is drinking liquid (bottled water) made by making biotite porphyry and granite ultra-fine by using strong acid such as hydrochloric acid or sulfuric acid. ing. On the other hand, (4) there is also a household appliance that reforms tap water with silicic acid solution (0.4 ppm/hr) eluted from Amagi anti-fire stone, but aluminum is detected and Alzheimer's is a factor. (5) Drinkable silica (silica 97ppm - produced in Kobayashi City, Miyazaki Prefecture), etc. In addition, (6) is a modified silicate mineral water (hot spring water), which is the primary raw material used for the health drink of the present invention, and is a natural resource modification stage including virus inactivation and bacteria sterilization. It is safe because it is implemented through reaction rate-limiting in mechanical engineering.
健康維持のための免疫改善飲用を目的とすれば、強アルカリの(1)、(3)は不適であり、(2)は金属ミネラルが豊富であるがケイ酸発現が少ない。(4)は素材からアルミニウムの溶出があり不特定多数の活用に不向きである。(5)は市販飲料水であるが、多飲の障害(腎臓結石等)に注意が必要である。(6)は多目的活用の改質液であり、安全な天然資源改質装置で成り立っている。 For the purpose of immune-improving drinking for health maintenance, strongly alkaline (1) and (3) are unsuitable, and (2) is rich in metallic minerals but has little silicic acid expression. (4) is unsuitable for many and unspecified uses due to the elution of aluminum from the material. (5) is commercially available drinking water, but attention should be paid to excessive drinking (kidney stones, etc.). (6) is a reforming solution for multi-purpose use and consists of a safe natural resource reforming device.
次に、表2の(5)の市販飲料水「商品名:のむシリカ」と、表2の(6)のケイ酸塩鉱物水(温泉水)を改質した改質水(温泉改質水と表記)と、この温泉改質水に有機酸としてのクエン酸及び重炭酸塩としての炭酸水素ナトリウムを溶解した本発明の健康飲料(添加SiO4重炭酸と表記)の成分について比較する。 Next, the modified water (hot spring reformed water) and the health drink of the present invention (denoted as added SiO 4 bicarbonate) in which citric acid as an organic acid and sodium bicarbonate as a bicarbonate are dissolved in this hot spring modified water.
市販飲料水の環境計量分析では、ケイ酸が45mg、シリカが77mgであり、ケイ酸比率(ケイ酸/シリカ)は45mg/77mg=58%である。一方、温泉改質水の場合は、ケイ酸が210mg、シリカが150mgであり、ケイ酸比率は210/150=140%である。ここで、上述したように、ケイ酸比率は100%以上(ケイ酸≧シリカ)が求められることから、本発明の健康飲料に使用する温泉改質水は市販飲料水に比べて優れていることが分かる。ちなみに、三朝温泉のケイ酸比率は22/60シリカ=37%である。玉造温泉のケイ酸比率は29/82シリカ=36%である。 Environmental quantitative analysis of commercial drinking water shows 45 mg of silicic acid and 77 mg of silica, and the silicic acid ratio (silicic acid/silica) is 45 mg/77 mg = 58%. On the other hand, in the case of hot spring modified water, silicic acid is 210 mg, silica is 150 mg, and the silicic acid ratio is 210/150=140%. Here, as described above, since the silicic acid ratio is required to be 100% or more (silicic acid ≥ silica), the hot spring modified water used for the health drink of the present invention is superior to commercially available drinking water. I understand. By the way, the silicic acid ratio of Misasa Onsen is 22/60 silica = 37%. The silicic acid ratio of Tamatsukuri Onsen is 29/82 silica = 36%.
また、粘性率(Viscosity)は、一般的な水道水1.0cPに対して、一次原料(温泉改質水)は0.825cPであり、この温泉改質水を用いて作製した本発明の健康飲料は0.9cPを示す。よって本発明の健康飲料は、粒子個数とともに腸内浸透と通過(アクアポリン及びパイエル板での吸収)に優れており、規則性のある代謝作用の根拠になっている。 In addition, the viscosity of the primary raw material (hot spring reformed water) is 0.825 cP compared to 1.0 cP of general tap water, and the health drink of the present invention produced using this hot spring reformed water It shows 0.9 cP. Therefore, the health drink of the present invention is excellent in intestinal penetration and passage (absorption in aquaporins and Peyer's patches) as well as the number of particles, which is the basis for regular metabolic action.
また、本発明の健康飲料に使用する温泉改質水に含まれるカルシウムやマグネシウム及びカリウムは、シリカ濃度で除した場合の値が1.0以下の場合には、上記の活性度の高いケイ酸SiO4基と十分に共有結合することから多元素共有の役割を担う。 In addition, when the value of calcium, magnesium, and potassium contained in the hot spring modified water used in the health drink of the present invention is 1.0 or less when divided by the silica concentration, the above-mentioned highly active silicate SiO 4 It has a multi-element covalent role because it bonds sufficiently covalently to groups.
この多元素共有ケイ酸塩は、構造形成イオンが水和の性質を発揮する代表であり、水溶性ケイ酸SiO4の増加に伴って生じたコロイド粒子のゼータ電位は、すべての包括されたミネラルにおいて陰電荷である。 This multi-element covalent silicate is representative of the structure-forming ions exhibiting the properties of hydration, and the zeta potential of the colloidal particles produced with the increase of the water - soluble silicate SiO4 is greater than that of all entrapped minerals. is a negative charge in
この多元素共有ケイ酸塩の非晶質化は、コロイド粒子のブラウン運動で確認できるが、特に無機質の10ナノサイズまで近づいた粒子運動迄であり、このナノサイズ計測範囲は0.01パーセント程度に過ぎない。また、無機質の微小生命体と称されるソマチットも計測可視で発現する。なお、ナノ粒子解析装置は英国製マルバーン社・日本カンタムデザイン(株)LM10型を用いている。 The amorphization of this multi-element covalent silicate can be confirmed by the Brownian motion of colloidal particles, but in particular, it is up to the particle motion approaching 10 nano-size of inorganic matter, and this nano-size measurement range is only about 0.01%. do not have. In addition, somatites, which are called inorganic micro-organisms, also appear in a measurable and visible way. For the nanoparticle analyzer, LM10 type manufactured by British Malvern Co., Ltd. and Nippon Quantum Design Co., Ltd. is used.
図1は、水溶性ケイ酸からなるコロイド粒子のサイズと体内への吸収効率との相関を示す図である。水溶性ケイ酸は8nmからコロイド粒子として検出可能であることから、10nm以上を図示している。図1に示すように、コロイド粒子のサイズが大きくなるに従って人体に取り込まれにくくなり、吸収効率が減少している。このように、ケイ酸を人体に効率的に取り込むためにはコロイド粒子のサイズは小さい方が好ましいが、一方、微細なコロイド粒子の作製は容易ではない。従って、ヒトのアクアポリン及び腸壁(パイエル板)での吸収を考慮すると、100nm以下、特に、葉面散布において最も一般的に使用されている40nm以下のサイズが好適であると言える。 FIG. 1 is a diagram showing the correlation between the size of colloidal particles made of water-soluble silicic acid and the absorption efficiency into the body. Since water-soluble silicic acid can be detected as colloidal particles from 8 nm, 10 nm or more is illustrated. As shown in FIG. 1, as the size of the colloidal particles increases, it becomes more difficult for them to be taken up by the human body, and the absorption efficiency decreases. As described above, colloidal particles should preferably have a small size in order to efficiently incorporate silicic acid into the human body, but on the other hand, it is not easy to produce fine colloidal particles. Therefore, considering absorption by human aquaporins and intestinal walls (Peyer's patch), it can be said that a size of 100 nm or less, especially 40 nm or less, which is most commonly used for foliar application, is suitable.
次に、図2乃至図4を参照して、市販飲料水の「商品名:のむシリカ」及び「商品名:ペリエ・フランス」と本発明のクエン酸と炭酸水素ナトリウムと水溶性ケイ酸とを含む健康飲料「商品名:スパークリングSiO4重炭酸」の水溶性ケイ酸のサイズについて比較する。なお、(a)のグラフの横軸はコロイド粒子のサイズ(nm)、縦軸は粒度(a.u.)であり、粒度分布が小さいほど微小コロイドが多く、計測限界以下の粒子が多い傾向にある。また、(b)のグラフの横軸はコロイド粒子のサイズ(nm)、縦軸は濃度(particles/ml)であり、左側の値が大きいほど微小コロイドが多いことを示している。 Next, referring to FIGS. 2 to 4, commercially available drinking water "trade name: Nomu Silica" and "trade name: Perrier France" and the citric acid of the present invention, sodium hydrogen carbonate and water-soluble silicic acid The size of the water-soluble silicic acid of the health drink "trade name: sparkling SiO 4 bicarbonate" containing In the graph (a), the horizontal axis represents the colloidal particle size (nm), and the vertical axis represents the particle size (au). The smaller the particle size distribution, the more fine colloids there are, and the more particles are below the measurable limit. In the graph (b), the horizontal axis represents the colloidal particle size (nm), and the vertical axis represents the concentration (particles/ml).
図2は、「のむシリカ」の分析結果であり、(a)はナノ粒子の分布図、(b)はNANOSIGHT分析結果である。商品表示ではシリカは97mg/lであり、ナノ粒子数は5.8億個/mlであるが、体内吸収に優れる40nm以下のサイズのナノ粒子の個数(図の破線で示す領域内の個数)が不足していることが分かる。また、pHは7である。 FIG. 2 shows the analysis results of "Drinkable silica", (a) is a distribution map of nanoparticles, and (b) is the NANOSIGHT analysis results. According to the product labeling, the amount of silica is 97 mg/l and the number of nanoparticles is 580 million/ml, but the number of nanoparticles with a size of 40 nm or less (the number within the area indicated by the dashed line in the figure), which is excellent for absorption into the body, is insufficient. I know you are. Also, the pH is 7.
図3は、「ペリエ・フランス」の分析結果であり、(a)はナノ粒子の分布図、(b)はNANOSIGHT分析結果である。ナノ粒子数は5.6億個/mlであるが、上記と同様に、体内吸収に優れる40nm以下のサイズのナノ粒子の個数(図の破線で示す領域内の個数)が不足していることが分かる。また、pHは8である。 FIG. 3 shows the analysis results of "Perrier France", (a) is a distribution map of nanoparticles, and (b) is the NANOSIGHT analysis results. Although the number of nanoparticles is 560 million/ml, it can be seen that the number of nanoparticles with a size of 40 nm or less (the number within the area indicated by the dashed line in the figure), which is excellent in body absorption, is insufficient. . Also, the pH is 8.
図4は、「スパークリングSiO4重炭酸」の分析結果であり、(a)はナノ粒子の分布図、(b)はNANOSIGHT分析結果である。粒子個数は2.08億個/mlであるが、重視すべきは、ケイ素含有量(ppm)ではなくヒトの吸収性に優れるサイズのナノ粒子であり、図の破線で示すように、体内吸収に優れる100nm以下、特に、40nm以下のサイズのケイ酸が多数存在していることが分かる。表4は、図4(b)の濃度分布の積分値であり、各サイズ範囲(0.5nmピッチ)における粒子個数、積算粒子個数、粒子比率%、積算粒子比率%を示している。表4より、100nm以下のサイズの粒子比率は、75.29%であり、粒子個数は、1.05億個/mlである。また、40nm以下のサイズの粒子比率は、7.02%であり、粒子個数は、0.098億個/mlである。 FIG. 4 shows the analysis results of “sparkling SiO 4 bicarbonate”, (a) is a distribution map of nanoparticles, and (b) is the NANOSIGHT analysis results. The number of particles is 208 million/ml, but what should be emphasized is not the silicon content (ppm), but the size of nanoparticles that are highly absorbable by humans. It can be seen that there are many silicic acids with a size of 100 nm or less, especially 40 nm or less. Table 4 shows integrated values of the concentration distribution in FIG. 4(b), showing the number of particles, cumulative number of particles, particle ratio %, and cumulative particle ratio % in each size range (0.5 nm pitch). From Table 4, the ratio of particles with a size of 100 nm or less is 75.29%, and the number of particles is 105 million/ml. Also, the ratio of particles with a size of 40 nm or less is 7.02%, and the number of particles is 0.098 million/ml.
また、スパークリングSiO4重炭酸500ccにはバランスの良いミネラル元素が含まれており、ナトリウム:9.0mg/0.5l、サルフェート:8.6mg/0.5l、マグネシウム:6.8mg/l、ケイ酸:4.2mg/l、カリウム:1.84mg/l、カルシウム:0.08mg/l、ホウ素:0.036mg/lなどがケイ酸と共有結合して多元素共有水溶性ケイ酸ミネラルとして存在している。表4の140~160nmは、ケイ素以外のミネラル(ナトリウム・サルフェート・マグネシウム・カリウム・カルシウム)がケイ酸と共有結合する粒子帯と考えられる。 In addition, sparkling SiO 4 bicarbonate 500cc contains well-balanced mineral elements, sodium: 9.0mg/0.5l, sulfate: 8.6mg/0.5l, magnesium: 6.8mg/l, silicic acid: 4.2mg/l. l, potassium: 1.84 mg/l, calcium: 0.08 mg/l, boron: 0.036 mg/l, etc. covalently bond with silicic acid and exist as multi-element covalent water-soluble silicate minerals. 140 to 160 nm in Table 4 is considered to be a particle band where minerals other than silicon (sodium, sulfate, magnesium, potassium, calcium) covalently bond with silicic acid.
以上説明したように、有機酸としてのクエン酸及び重炭酸塩としての炭酸水素ナトリウムが溶解された溶解水に水溶性ケイ酸を混合し(若しくは、水溶性ケイ酸を含有する改質水に有機酸としてのクエン酸及び重炭酸塩としての炭酸水素ナトリウムを溶解し)、必要に応じて、炭酸ガスを圧入して健康飲料を製造することにより、ケイ酸を効率的に体内に取り込むことができる。 As described above, water-soluble silicic acid is mixed with dissolution water in which citric acid as an organic acid and sodium hydrogen carbonate as a bicarbonate are dissolved (or organic By dissolving citric acid as an acid and sodium bicarbonate as a bicarbonate) and, if necessary, injecting carbon dioxide gas to produce a health drink, silicic acid can be efficiently taken into the body. .
本発明の健康飲料は、クエン酸と重炭酸を混合した溶解水に、一般的に表現される、ケイ素又はシリカ及びケイ酸とは異なり、多元素共有の中心に位置する水溶性ミネラルを一定量加えたものであり、生体内ラジカルの発生に対して効率的にラジカル補足抑制作用を発揮する優れた健康飲料の逸品である。 The health drink of the present invention contains a certain amount of water-soluble minerals located at the center of multi-element sharing, unlike silicon or silica and silicic acid, which are generally expressed in dissolved water in which citric acid and bicarbonate are mixed. It is a gem of an excellent health drink that effectively exerts a radical-scavenging-suppressing action against the generation of radicals in the body.
本発明が身近で理解できるのは、体内の抗酸化作用で疲れにくくなることであり、例えば、風邪の症状では、熱は出ずクシャミと咳で翌日治るなどである。本発明の健康飲料を毎朝飲用すると、2時間後には排尿作用が現れ、規則性が必ず感じる。また、食前に飲用すると、糖尿病のインスリン効果が優れ体調維持が好調である。定期的な血液検査でも改善事例が現れる等、効果が体感出来ている。本発明の健康飲料は機能性表示食品であり、多元素共有ミネラルの必要性は、2019/9/04放送のNHK報道番組「ガッテン」でも、『人体には60種類の金属ミネラルを必要とする。』と報道している。 What the present invention is familiar and understandable is that the antioxidant action in the body reduces fatigue. For example, in the case of cold symptoms, there is no fever but sneezing and coughing, and the next day the person recovers. When the health drink of the present invention is drunk every morning, the urination effect appears 2 hours later, and regularity is always felt. In addition, when taken before a meal, the insulin effect for diabetes is excellent, and physical condition maintenance is good. We can feel the effects, such as improvement cases appearing even in regular blood tests. The health drink of the present invention is a food with functional claims. . ’ is reported.
また、本発明の健康飲料は、飲用直後に強酸性の胃液と健康飲料とが中和反応してpHは弱酸性域となり、げっぷ作用で炭酸ガスが抜気され、pHは高い緩衝作用の重曹クエン酸の特性により中性域となり、腸内でのケイ酸の吸収性も高められるバッファー効果が発揮される。強炭酸ガス濃度で、強炭酸などと称するpHが2.0~4.8程度の強酸性商品とは全く異なる特性を発揮する。このように、本発明の健康飲料は、pHを5.5~8.3に調整しているため、それ自体で胃壁を損傷させることなく、胃酸消化を経て腸に運ばれ、血糖値上昇を抑制するなどの効果を得ることができる。 In addition, in the health drink of the present invention, the strongly acidic gastric juice and the health drink undergo a neutralization reaction immediately after drinking, resulting in a weakly acidic pH. Due to the properties of citric acid, it becomes a neutral range and exerts a buffer effect that enhances the absorption of silicic acid in the intestine. At a strong carbon dioxide gas concentration, it exhibits properties that are completely different from strongly acidic products with a pH of about 2.0 to 4.8 called strong carbonic acid. As described above, the health drink of the present invention has a pH adjusted to 5.5 to 8.3, so that it does not damage the stomach wall by itself, and is transported to the intestine through gastric acid digestion, thereby suppressing the increase in blood sugar level. effect can be obtained.
なお、本発明は上記実施例に限定されるものではなく、本発明の趣旨を逸脱しない限りにおいて、その構成は適宜変更可能である。 It should be noted that the present invention is not limited to the above embodiments, and its configuration can be changed as appropriate without departing from the gist of the present invention.
例えば、上記実施例では、本願発明者の先願(特許第6698766号)に記載した有機酸としてのクエン酸及び重炭酸塩としての炭酸水素ナトリウムを含む溶解水に水溶性ケイ酸を加えて健康飲料を作製したが、上記溶解水と同等の成分を有する溶液に水溶性ケイ酸を加えて健康飲料を作製してもよい。また、上記実施例では、水溶性ケイ酸を含有する温泉改質水に有機酸としてのクエン酸及び重炭酸塩としての炭酸水素ナトリウムを溶解して健康飲料を作製したが、上記温泉改質水と同等の成分を有する改質水(例えば、湧出地下水を改質した改質水)にクエン酸及び炭酸水素ナトリウムを溶解して健康飲料を作製してもよい。 For example, in the above examples, water-soluble silicic acid is added to the dissolved water containing citric acid as the organic acid and sodium hydrogen carbonate as the bicarbonate described in the prior application (Patent No. 6698766) of the inventor of the present application, and the health benefits are obtained. A beverage was prepared, but a health drink may be prepared by adding water-soluble silicic acid to a solution having the same components as the dissolved water. Further, in the above example, the health drink was prepared by dissolving citric acid as an organic acid and sodium hydrogen carbonate as a bicarbonate in the hot spring reformed water containing water-soluble silicic acid. A health drink may be prepared by dissolving citric acid and sodium bicarbonate in modified water (for example, modified water obtained by modifying seep groundwater) having the same components as .
また、上記実施例では、本願発明者の他の先願(特許第6328403号)に記載した機能性水製造装置を用いて温泉水から水溶性ケイ酸を抽出したが、化学合成以外で水溶性ケイ酸を抽出できれば、製造装置や水溶性ケイ酸を抽出する溶液は特に限定されない。 In the above examples, water-soluble silicic acid was extracted from hot spring water using the functional water production device described in another prior application (Patent No. 6328403) of the present inventor. As long as the silicic acid can be extracted, the manufacturing apparatus and the solution for extracting the water-soluble silicic acid are not particularly limited.
本発明は、有機酸と重炭酸塩と水溶性ケイ酸とを含有する健康飲料に利用可能である。 INDUSTRIAL APPLICABILITY The present invention is applicable to health drinks containing organic acid, bicarbonate and water-soluble silicic acid.
Claims (11)
ことを特徴とする請求項1に記載の健康飲料。 The health drink is obtained by mixing the water-soluble silicic acid with the dissolved water in which the citric acid and the sodium hydrogen carbonate are dissolved, and injecting carbon dioxide gas.
The health drink according to claim 1, characterized by:
ことを特徴とする請求項1に記載の健康飲料。 The health drink is obtained by dissolving the citric acid and the sodium hydrogen carbonate in the modified water containing the water-soluble silicic acid, and injecting carbon dioxide gas.
The health drink according to claim 1, characterized by:
ことを特徴とする請求項1乃至3のいずれか一に記載の健康飲料。 In the health drink, the sodium hydrogen carbonate is dissolved at a mass ratio of 2 to 8 with respect to the citric acid 1.
The health drink according to any one of claims 1 to 3, characterized by:
ことを特徴とする請求項1乃至4のいずれか一に記載の健康飲料。 The health drink has a hydrogen ion concentration (pH) of 5.5 or more and 8.3 or less.
5. The health drink according to any one of claims 1 to 4, characterized by:
ことを特徴とする請求項1乃至5のいずれか一に記載の健康飲料。 The water-soluble silicic acid forms colloidal particles, and the health drink contains the colloidal particles with a size of 100 nm or less.
The health drink according to any one of claims 1 to 5, characterized by:
ことを特徴とする請求項6に記載の健康飲料。 The colloidal particles having a size of 100 nm or less have a particle ratio of 75% or more, or a particle number of 100 million particles/ml or more.
The health drink according to claim 6, characterized by:
ことを特徴とする請求項6又は7に記載の健康飲料。 The colloidal particles having a size of 40 nm or less have a particle ratio of 7% or more, or a particle number of 0.9 billion/ml or more.
The health drink according to claim 6 or 7, characterized by:
ことを特徴とする請求項6乃至8のいずれか一に記載の健康飲料。 The health drink contains minerals other than silicon, and the water-soluble silicic acid covalently bonds with the minerals to form the colloidal particles.
The health drink according to any one of claims 6 to 8, characterized by:
ことを特徴とする請求項1乃至9のいずれか一に記載の健康飲料。 The health drink contains water-insoluble silica and the water-soluble silicic acid as silicon, and the component ratio of the water-soluble silicic acid to the water-insoluble silica is 100% or more.
The health drink according to any one of claims 1 to 9, characterized by:
ことを特徴とする請求項1乃至10のいずれか一に記載の健康飲料。 The water-soluble silicic acid is extracted from hot spring water or groundwater,
The health drink according to any one of claims 1 to 10, characterized by:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021014275A JP2022117659A (en) | 2021-02-01 | 2021-02-01 | Healthy drink |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021014275A JP2022117659A (en) | 2021-02-01 | 2021-02-01 | Healthy drink |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2022117659A true JP2022117659A (en) | 2022-08-12 |
Family
ID=82750354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021014275A Pending JP2022117659A (en) | 2021-02-01 | 2021-02-01 | Healthy drink |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2022117659A (en) |
-
2021
- 2021-02-01 JP JP2021014275A patent/JP2022117659A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rosborg et al. | Drinking water minerals and mineral balance | |
CN101456642A (en) | Method for producing high magnetic activated water | |
CN101744336B (en) | Mineralized soda water | |
CN105905426A (en) | Beverage bottle capable of generating healthy water | |
WO2017185435A1 (en) | Composite mineralized ceramic material capable of producing active hydrogen healthcare water | |
JP2022117659A (en) | Healthy drink | |
CN104803541B (en) | The method of the middle temperature contravariant deoxidation hydrogenation of mineralising micromolecular water | |
CN101993141A (en) | Drinking water and production method thereof | |
CN104207642B (en) | Big-power solar energy mineral water drinking machine | |
CN101268997A (en) | Complexing form wash and bath liquid of natural mineral matter and micro-element, and preparation method | |
CN108503009A (en) | A kind of guarantee mineralising selenium-rich water security drinking system | |
JP4944166B2 (en) | Method for providing natural calcium derived from living organisms in nano-state | |
JPH04166290A (en) | Method for finely dividing group of molecule of water, solution containing water-soluble mineral used therefor and production thereof | |
JP2008023520A (en) | Drinking water production method and apparatus | |
US20090214711A1 (en) | Drinking water formulation and method and article relating to same | |
KR101206187B1 (en) | Method for manufacuring loess active water with micro-nanobubble oxygen active water characteristics and alcoholic liquors using far infrared ray characteristics | |
JP2007284420A (en) | Water having anticancer property and method for producing the same water | |
JP2005211765A (en) | Health drinking water, and apparatus and method for producing the same | |
CN104591366B (en) | Volcanic rock water activating agent and preparation method thereof | |
JP2006000004A (en) | Foaming soft drink | |
CN1163426C (en) | Physically activated drinking water and its producing method | |
RU2741383C1 (en) | Composite concentrate for preparation of mud baths and artificial therapeutic mud | |
RU2763187C1 (en) | Functional drinking water “smart aqua” for giving vivacity, strength and energy to a person | |
CN1033349A (en) | The method for making of laughable series beverage | |
WO2024158680A1 (en) | Aqueous formulation including dissolved hydrogen gas and minerals and additives and water dispensing device producing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240109 |